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Research
Extensive epidemiological evidence indicates 
a strong and positive correlation between 
exposure to airborne particulate matter (PM) 
and cardio  vascular morbidity and mortality 
(Bhatnagar 2006; Brook et al. 2010). Short-
term exposure to PM is associated with an 
increase in the risk of myocardial infarction, 
arrhythmias, endothelial dysfunction, stroke, 
and thrombosis, whereas chronic exposures 
increase the risk of mortality due to ischemic 
heart disease, arrhythmias, and heart failure. 
Nevertheless, the mechanisms by which PM 
exposure elevates cardio  vascular disease (CVD) 
risk remain unclear.
Because PM exposure affects several aspects 
of cardio  vascular disease, it is likely that it 
alters cardio  vascular processes that are com-
mon to several manifestations of CVD. One 
such unifying mechanism that could contrib-
ute to multiple aspects of CVD is endothelial 
dysfunction. Changes in endothelial reac-
tivity affect not only blood pressure regula-
tion but also athero  genesis, heart failure, and 
arrhythmo  genesis (Landmesser et al. 2004). 
Thus, PM-induced endothelial dys  function 
could potentially explain several cardio-
vascular effects of PM exposure. Data from 
both human and animal studies indicate that 
changes in endothelial function are early and 
sensitive outcomes of PM exposure (Brook 
et al. 2009; Courtois et al. 2008).
Recent advances in vascular biology sug-
gest that endothelial health and function are 
in part maintained by a replenishing pool 
of progenitor cells that reside mostly in the 
bone marrow. Upon tissue injury, endothe-
lial progenitor cells (EPCs) are recruited to 
the site of damage where they participate in 
angio  genesis by differentiating into mature 
endothelial cells or by paracrine stimu  la  tion 
of existing cells (Hristov and Weber 2009). 
Levels of circulating EPCs are a sensitive 
index of endothelial health and are inversely 
correlated with CVD risk (Hill et al. 2003; 
Steinmetz et al. 2010). Unhealthy life  style 
factors, smoking (Yue et al. 2010), or acrolein 
exposure (Wheat et al. 2011) suppress EPC 
levels, indicating that EPC depletion may 
be a significant contributory factor linking 
pollutant exposure to CVD risk. Indeed, our 
recent studies show that short-term exposure 
to PM decreases circulating levels of EPCs 
in humans and mice (O’Toole et al. 2010). 
Nevertheless, the mechanisms by which 
PM exposure suppresses EPC levels are not 
known; it is unclear whether PM depletes 
EPCs by triggering cell death, stimulating the 
recruitment of these cells to injured tissue, or 
preventing their mobilization from the bone 
marrow. Accordingly, the present study was 
designed to investigate the nature of the EPC 
defect induced by PM2.5 (particulate matter 
< 2.5 µm in aerodynamic diameter) and to 
identify specific processes involved in EPC 
mobilization and homing that are affected by 
PM2.5 exposure.
Materials and Methods
PM2.5 and concentrated ambient particle 
(CAP) analysis. Ambient PM2.5 was collected 
between June 2009 and December 2010 at 
the Medical and Dental Research building 
(7th floor) at the Health Science Center, 
University of Louisville (Louisville, KY; 
38°15´15˝N/85°45´33˝W). Ambient PM2.5 
was concentrated using a versatile aerosol con-
centration enrichment system (VACES). A 
single-stage stainless steel filter holder with 
a teflon filter (47 mm diameter) was used to 
collect ambient PM2.5 or CAP at 10 L/min or 
1 L/min air flow rate, respectively. Collected 
PM mass concentrations were determined 
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Exposure to Ambient Air Fine Particulate Matter Prevents VEGF-Induced 
Mobilization of Endothelial Progenitor Cells from the Bone Marrow
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Ba c k g r o u n d: Exposure to ambient fine particulate matter air pollution (PM2.5; < 2.5 µm in aero-
dynamic diameter) induces   endothelial dysfunction and increases the risk for cardio  vascular disease. 
Endothelial progenitor cells (EPCs) contribute to post  natal endothelial repair and regeneration. In 
humans and mice, EPC levels are decreased upon exposure to elevated levels of PM2.5.
oB j e c t i v e: We examined the mechanism by which PM2.5 exposure suppresses circulating levels of 
EPCs. 
Me t h o d s : Mice were exposed to HEPA-filtered air or concentrated ambient fine particulate matter 
(CAP, 30–100 µg/m3) from downtown Louisville (Kentucky) air, and progenitor cells from periph-
eral blood or bone marrow were analyzed by flow cytometry or by culture ex vivo.
re s u l t s: Exposure of the mice to CAP (6 hr/day) for 4–30 days progressively decreased circulating 
levels of EPCs positive for both Flk-1 and Sca-1 (Flk-1+/Sca-1+) without affecting stem cells positive 
for Sca-1 alone (Sca-1+). After 9 days of exposure, a 7-day exposure-free period led to complete 
recovery of the circulating levels of Flk-1+/Sca-1+ cells. CAP exposure decreased circulating levels 
of EPCs independent of apoptosis while simultaneously increasing Flk-1+/Sca-1+ cells in the bone 
marrow. We observed no change in tissue deposition of these cells. CAP exposure suppressed 
vascular endothelial growth factor (VEGF)-induced Akt and endothelial nitric oxide synthase 
(eNOS) phosphorylation in the aorta, and it prevented VEGF/AMD3100-induced mobilization 
of Flk-1+/Sca-1+ cells into the peripheral blood. Treatment with stem cell factor/AMD3100 led to 
a greater increase in circulating Flk-1+/Sca-1+ cells in CAP-exposed mice than in mice breathing 
filtered air.
co n c l u s i o n: Exposure to PM2.5 increases EPC levels in the bone marrow by preventing their 
mobilization to the peripheral blood via inhibition of signaling events triggered by VEGF-receptor 
stimulation that are upstream of c-kit activation. Suppression of EPC mobilization by PM2.5 could 
induce deficits in vascular repair or regeneration.
key w o r d s : air pollution, AMD3100, CAP, cardio  vascular disease, environmental cardiology, flow 
cytometry, PM2.5, SCF, stem cells, VEGF. Environ Health Perspect 120:848–856 (2012).  http://
dx.doi.org/10.1289/ehp.1104206 [Online 14 March 2012]PM2.5 inhibits progenitor cell mobilization
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gravimetrically using a micro  balance in a room 
with controlled temperature and humidity. 
Analy  sis of ambient PM2.5 and CAP filters 
indicated a VACES PM2.5 concentration fac-
tor of 2.7- to 9.3-fold. CAP concentrations 
varied between experi  ments as a function of 
ambient PM2.5 levels and meteoro  logical con-
ditions, including temperature and relative 
humidity [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1104206)]. In 
addition, a nephelometer was used to measure 
real-time CAP mass concentration and mass 
median diameter. 
For analysis of ambient PM2.5 or CAP 
chemical composition and physical properties, 
particles were collected using different filter 
types. The organic carbon and elemental 
carbon compositions were analyzed by a 
thermal-optical analysis technique. Standard 
U.S. Environmental Protection Agency 
(EPA) methods were used to analyze sulfate, 
nitrate, and ammonium ion levels. Elemental 
analysis was conducted by X-ray fluorescence 
spectrometry. 
Particle size distributions of ambient 
PM2.5 and CAP were analyzed as geomet-
ric particle number distributions using a 
filter-based particle size analyzer (Malvern 
Mastersizer 2000; Malvern Instrument Ltd., 
Worcestershire, UK). The relative refractive 
index on the applied particle size analyzer was 
1.16. To better charac  terize the relation  ship 
between CAP exposure and EPC suppression, 
exposure duration and cumulative CAP load 
were regressed against EPC level. The esti-
mate of CAP load was calculated as follows: 
CAP (micrograms per cubic meter) × cham-
ber flow (cubic meters per minute) × exposure 
time (minutes). We estimated lung deposition 
of PM for each specific exposure using mouse 
tidal volume, breathing frequency, and an esti-
mated deposition fraction. See Supplemental 
Material, pp. 3–4 (http://dx.doi.org/10.1289/
ehp.1104206) for additional details. 
Mice and exposures. Mice were treated 
humanely and with regard for alleviation of 
suffering according to the Guiding Principles 
in the Care and Use of Animals (American 
Physiological Society 2012). All protocols 
were approved by the University of Louisville 
Institutional Animal Care and Use Committee. 
Male C57BL/6J mice (8–12 weeks of age; 
Jackson Laboratory, Bar Harbor, ME) were 
exposed to HEPA-filtered air or concentrated 
ambient PM2.5 (CAP). 
Progenitor cell mobilization. To mobi-
lize progenitor cells, mice were injected sub-
cutaneously with recombinant murine 
VEGF165 (vascular endothelial growth factor) 
in saline (0.1 mL, 100 µg/kg/day; Peprotech, 
Inc., Rocky Hill, NJ) daily for 4 consecutive 
days (Pitchford et al. 2009). In another group, 
mice were injected sub  cutaneously with a sin-
gle bolus of stem cell factor (SCF; 0.1 mL, 
200 µg/kg; Peprotech, Inc.). In both proto-
cols, mice received the CXCR4 (chemokine 
X receptor type 4) antagonist AMD3100   
(5 mg/kg, intra  peritoneal injection, 0.1 mL in 
saline; Sigma-Aldrich, St. Louis, MO) or saline 
alone (0.1 mL; control). Blood, bone marrow, 
and tissues were harvested 1 hr after AMD3100 
or saline injection. See Supplemental Material 
(http://dx.doi.org/10.1289/ehp.1104206) for 
additional details. 
Isolated aorta studies. Thoracic aortas 
were isolated for assessment of either VEGF 
signaling or vascular reactivity as described 
previously (Wheat et al. 2011; Conklin et al. 
2009) with some modifications.
VEGF signaling. Thoracic aortas from dis-
tal of the aortic arch to the diaphragm were 
isolated from mice exposed for 9 days to air or 
CAP, cleaned in cold phosphate-buffered saline 
(PBS), and then placed in autologous plasma 
for 1 hr at 37°C prior to addition of saline 
(vehicle) or VEGF (20 ng/mL) for 15 min. 
After incubation, aortas were snap frozen in 
liquid nitrogen and stored at –80°C before use 
for Western blotting. 
Vascular reactivity. Briefly, one 3–4-mm 
aortic ring per mouse was hung on stainless steel 
hooks in 15-mL water-jacketed organ baths in 
physiological salt solution bubbled with 95% 
O2 and 5% CO2 at 37°C. Aortic rings were 
contracted with 100 mM potassium solution 
twice and reequilibrated to approximately 
1 g over 2 hr before measuring endothelial 
function. To measure endothelium-dependent 
relaxation, phenylephrine-precontracted aortas 
were relaxed with cumulative concentrations 
of acetylcholine. To measure endothelium-
independent relaxation, aortas were pre-
contracted with either 100 mM potassium 
(9-day study) or with U46619 (thromboxane 
A2 analog, 0.1 µM; 30-day study) and then 
relaxed with cumulative concentrations 
of sodium nitroprusside. Relaxation was 
calculated as a percentage reduction of agonist-
induced tension. For additional details, see 
Supplemental Material, pp. 6–7 (http://dx.doi.
org/10.1289/ehp.1104206). 
Flow cytometry. Mononuclear cells 
from peripheral blood or bone marrow were 
separated by Ficoll gradient centrifugation 
and immuno  labeled with PE-anti-Sca-1 
(phycoerythrin-conjugated stem cell antigen-1) 
and APC-anti-Flk-1 [allophycocyanin-
conjugated fetal liver kinase-1 (VEGFR2, 
vascular endothelial growth factor receptor 2), 
1 µg; BD BioSciences, San Jose, CA]. The 
number of cells positive for both Flk-1 and 
Sca-1 (Flk-1+/Sca-1+) and those positive for 
Sca-1 alone (Sca-1+) were measured by flow 
cytometry using an LSRII flow cytometer 
(BD BioSciences) and analyzed with FlowJo 
v8 software (Treestar Inc., Ashland, OR). 
For measuring apoptosis, the mono  nuclear 
cell population was incubated with Annexin 
Binding Buffer (100 µL for 15 min at room 
temperature; Annexin Kit; eBioscience, San 
Diego, CA) and labeled with Flk-1 and Sca-1 
anti  bodies. To detect necrosis, the cells were 
labeled with 7-AAD (7-amino  actinomycin D; 
5 µL; eBioscience) and analyzed by flow 
cytometry. After select exposures, 100 µL 
whole blood was used for complete blood 
count analysis (CBC; Hemavet 500; Coulter 
Counter, Oxford, CT).
Cell culture. Mononuclear cells from blood 
(1 × 105 to 4 × 105 cells) and Ficoll-separated 
bone marrow (8 × 105 cells) were cultured 
for 4 or 7 days, respectively. After incubation 
with DiI-acLDL (1,1´-dioctadecyl-3,3,3´,3´-
tetramethyl  indo  carbocyanine perchlorate-
acetylated low density lipoprotein, 2.4 µg/mL;   
Molecular Probes, Invitrogen, Carlsbad, CA) 
for 3 hr (37°C, 5% CO2), blood cells were 
fixed in 4% paraformaldehyde/PBS, pH 7.4 
(10 min at room temperature) and incubated 
with FITC-UE-lectin (fluorescein iso  thio-
cyanate–Ulex europaeus-lectin; 50 µg/mL,   
30 min, 37°C; Sigma-Aldrich). To label 
bone marrow-derived cells (BMDCs), fixed 
cells were incubated with FITC-Sca-1 (1:25; 
BD BioSciences) and APC-Flk-1 (1:15, BD 
BioSciences) anti  bodies (1 hr at room temper-
ature). Slides were mounted with DAPI (4´,6-
diamidino-2-phenylindole)-containing Slow 
Fade® Gold anti-fade reagent (Invitrogen); 
DiI-acLDL+/FITC-UE-lectin+ or FITC-
Sca-1+/APC-Flk-1+ cells were counted in 
10 random microscopic fields. For the tube-
forming assay, 4 × 104 BMDC were seeded 
into Matrigel™-coated plates and microscopic 
images were acquired after 24 hr in culture.
Western blot analyses. Proteins in the tis-
sue lysates of heart, lung, spleen, and pulver-
ized aortas [see Supplemental Material, p. 7 
(http://dx.doi.org/10.1289/ehp.1104206)] 
were separated by SDS-PAGE, transferred 
to PVDF membranes and probed with anti-
bodies against VEGFR-2, phosphorylated 
(phospho)-Akt (Ser473), Akt, phospho-eNOS 
(phosphorylated endothelial nitric oxide syn-
thase; Ser1177), and eNOS (1:1,000), all 
from Cell Signaling Technology (Danvers, 
MA) or Id-1 (inhibitor of DNA binding 1; 
1:1,000, Proteintech, IL), as described previ-
ously (Wheat et al. 2011). See Supplemental 
Material, p. 7 (http://dx.doi.org/10.1289/
ehp.1104206) for additional details. 
Statistical analysis: Data presented are 
mean ± SE. We used Student’s t-test for two-
group comparison and one-way analysis of 
variance (Bonferroni post hoc test) for mul-
tiple group comparison. Statistical significance 
was accepted at p < 0.05.
Results
Louisville PM2.5 and VACES charac  terization. 
Ambient PM2.5 was concentrated using a 
VACES, and the CAP concentration varied Haberzettl et al.
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between experiments as a function of ambient 
PM2.5 levels and meteorological conditions 
[e.g., temperature and relative humidity; see 
Supplemental Material, Table 1 (http://dx.doi.
org/10.1289/ehp.1104206)]. We observed 
little difference between ambient PM2.5 and 
chemical composition and physical properties 
of CAP (organic carbon, elemental carbon, sul-
fate, nitrate, ammonium, elements, particle size 
distribution; Figure 1). For example, ambient 
PM2.5 and CAP showed no significant differ-
ence of mass fraction (as a percentage) in chem-
ical or elemental composition (Figure 1A,C; 
see also Supplemental Material, Table 2). The 
number median diameter of ambient PM2.5 
(0.33 µm for August 2009; 0.36 µm for June 
2010) was similar to CAP number median 
diameter (0.53 µm, August 2009; 0.38 µm, 
June 2010) (Figure 1B). These data indicate 
the VACES concentrated ambient PM2.5 but 
did not alter its specific properties.
CAP exposure decreases the levels of cir-
culating EPC. Our previous study (O’Toole 
et al. 2010) showed that 9-day CAP exposure 
decreases circulating levels of EPCs in mice; 
however, we did not examine either the nature 
or the mechanism of this response. Hence, 
to understand the effects of CAP on EPCs, 
we first examined the time course and revers-
ibility of the response. EPC levels in the blood 
were measured by counting events positive 
for endothelial (Flk-1) and stem cell (Sca-1) 
antigens using flow cytometry (Figure 2A). 
Flk-1+/Sca-1+ cells were gated in the lympho-
cytic popula  tion as indicated in the representa-
tive flow cytometry plots of side scatter and 
forward scatter (Figure 2A, top). The number 
of cells positive for both PE-Sca-1 and APC-
Flk-1 (PE-Sca-1+/APC-Flk-1+) was counted 
from plots, and the percentage of total gated 
cells isolated from mice exposed for 9 days to 
either HEPA-filtered air or CAP showed fewer 
EPCs following CAP exposure (Figure 2A, 
bottom). For additional characterization, blood 
cells were cultured for 4 days (Figure 2B) and 
uptake of DiI-acLDL and binding to FITC-
UE-lectin were analyzed. Microscopic images 
showed the outgrowth of DiI-acLDL+/FITC-
UE-lectin+ spindle-shaped cells, as indicated by 
arrow in the merged images. Most of these cells 
were positive for both endothelial cell–specific 
markers (76 ± 7%; Figure 2B, merged images). 
Previous analysis shows that these cells are 
3–5 µm in diameter and are posi  tive for Id-1, 
CXCR4, and several other progenitor and lym-
phocytic cell markers (Wheat et al. 2011).
To examine whether PM2.5 exposure leads 
to a progressive decrease in EPC levels, we 
exposed mice to CAP (6 hr/day) for 4, 9, or 
30 days. As shown in Figure 2C, CAP exposure 
led to a progressive decrease in the number of 
circulating Flk-1+/Sca-1+ cells; however, we 
observed no significant changes in the levels 
of Sca-1+ cells (Figure 2D). Complete blood 
count (CBC) analyses showed no effect of CAP 
exposure on the numbers of leukocytes or red 
blood cells [see Supplemental Material, Table 3 
(http://dx.doi.org/10.1289/ehp.1104206)]. 
Time-course analysis revealed a non  linear 
relationship between dose and EPC level. 
A steep decline in EPC levels was observed 
within 4 days of CAP exposure (33% decrease; 
p < 0.05); whereas longer exposures were 
associated with a shallower response. The half-
maximal response duration (ED50) calculated 
from a first-order exponential equation was 
approximately 12 days (Figure 2E). The dose–
response relationship was non  linear with an 
ED50 value of < 1 µg cumulative pulmonary 
CAP load (Figure 2F). Suppression of 
circulating EPC levels by CAP was reversible. 
After 9 days of exposure, a 7-day exposure-
free period led to complete recovery of 
circulating Flk-1+/Sca-1+ cells (Figure 2G). 
These observations indicate that exposure to 
CAP results in a rapid, specific, and reversible 
decrease in circulating EPC levels at low 
cumulative doses of CAP exposure.
CAP exposure does not induce EPC death 
or tissue deposition. CAP-induced depletion of 
circulating EPCs could be due to an increase 
in cell death (apoptosis/necrosis), enhanced 
recruitment/homing to sites of injury, or a 
decrease in mobilization from bone marrow. 
Hence, we tested each of these possibilities. To 
determine whether CAP-induced EPC deple-
tion was due to an increase in EPC death, we 
examined apoptosis and necrosis in the circu-
lating Flk-1+/Sca-1+ cell population by flow 
cytometry. Exposure to CAP depleted circulat-
ing Flk-1+/Sca-1+ cells; however, we did not 
observe an increase in markers of apoptosis 
(Annexin-V+) or necrosis (7AAD+) compared 
with exposure to filtered air [see Supplemental 
Material, Figure 1A,B (http://dx.doi.
org/10.1289/ehp.1104206)]. These results sug-
gest that EPC depletion in CAP-exposed mice 
is not due to an increase in cell death.
To test the possibility that EPCs are 
depleted due to increased recruitment to sites 
of injury (e.g., lung) or other stem cell niches 
(e.g., spleen), we measured the abundance of 
the EPC-specific protein Id-1 (Mellick et al. 
2010) by Western blot analysis. Immunoblots 
of lysates prepared from lung, aorta, heart, 
and spleen showed no differences in the 
abundance of Id-1 protein in these organs 
after 9 days of exposure to air or CAP [see 
Supplemental Material, Figure 1C (http://
dx.doi.org/10.1289/ehp.1104206)]. Thus, 
EPC depletion in CAP-exposed mice could 
not be attributed to an increase in EPC 
recruitment to sites of injury or other stem cell 
niches. Hence, we studied the effects of CAP 
exposure on EPC mobilization.
CAP exposure increases resident EPCs in 
bone marrow. We examined PM2.5-induced 
changes in bone marrow EPCs by culturing 
cells from the bone marrow on fibronectin-
coated plates for 7 days. Nearly 90% of 
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as a nuclear marker; the numbers of DiI-acLDL+, FITC-UE-lectin+, and DiI-acLDL+/FITC-UE-lectin+ cells are presented as the mean ± SE percentage of total cells 
(identified by DAPI staining) counted in five random microscopic fields. (C,D) Change in Flk-1+/Sca-1+ (C) and Sca-1+ (D) cell populations after CAP exposure for 
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a best fit of a first-order exponential equation [(y = y0 + a1exp(–x/t1)] to the data. In F, numbers 1–4 refer to specific CAP exposures shown in Supplemental Material, 
Table 1 (http://dx.doi.org/10.1289/ehp.1104206). (G) Circulating Flk-1+/Sca-1+ cells (percentage of air control) in mice exposed for 9 days to air or CAP without and 
with 7 days of recovery. In C–G, data are mean ± SE (n = 4–6).
*p < 0.05 compared with air control. Haberzettl et al.
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Figure 3. CAP exposure increases bone marrow resident Flk-1+/
Sca-1+ cells. (A) Fluorescence images (top, 10×; bottom, 40×) of 
bone marrow-derived DiI-acLDL+/FITC-UE-lectin+ cells isolated 
from unexposed animals and cultured for 7 days. Merged 
images show DiI-acLDL+/FITC-UE-lectin+ cells in orange (right) 
with DAPI as a nuclear marker. The numbers of DiI-acLDL+, 
FITC-UE-lectin+, and DiI-acLDL+/FITC-UE-lectin+ cells were 
counted in five random microscopic fields, and the numbers 
of cells are presented as the mean ± SE percentage of total 
cells (identified by DAPI staining). (B) Tube formation (arrows) 
by EPCs isolated from bone marrow, cultured for 10 days, and 
then seeded on Matrigel™. (C) Representative flow cytom-
etry plots of side scatter (SSC) and forward scatter (FSC) or 
PE-Sca-1+/APC-Flk-1+ fluorescence in cells isolated from bone 
marrow of mice exposed for 9 days to air or CAP. Numbers 
within the plots indicate the percentage of PE-Sca-1+/APC-
Flk-1+ cells within the lymphocytic gate. (D) Changes in Flk-1+/
Sca-1+ cells in bone marrow from mice exposed for 9 days to 
air or CAP (mean ± SE percent of control; n = 4–5).
*p < 0.05. PM2.5 inhibits progenitor cell mobilization
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outgrowing spindle-shaped cells were positive 
for acLDL uptake and UE-lectin binding 
(Figure 3A). After 10 days in culture, these 
cells formed tube-like structures (Figure 3B) 
when seeded on Matrigel, indicating that 
they had differentiated into endothelial cells. 
To determine the effects of PM2.5 on this 
cell population, we exposed mice to CAP for 
9 days and measured bone marrow Flk-1+/
Sca-1+ cells by flow cytometry (Figure 3C). 
We found that in contrast to decreased 
EPC levels in blood, CAP-exposure led to a 
significant increase in the number of resident 
EPCs in bone marrow (Figure 3D). 
To confirm this finding, we isolated 
bone marrow from mice exposed for 9 days 
to CAP or filtered air and cultured the cells 
in fibronectin-coated dishes. Clusters of cells 
(cluster forming unit; CFU) appeared within 
24 hr after seeding and were counted after 
2, 4, and 7 days in culture (Figure 4A; typically 
5–20 CFU/well). Cultures of bone marrow 
cells from CAP-exposed mice developed 50% 
more CFUs than those from mice breathing 
filtered air (Figure 4B). In both groups, the 
number of clusters dissipated within 7 days 
of culture, giving rise to spindle-shaped cells 
(Figure 4A), which stained positive for Sca-1 
and Flk-1, as well as for acLDL and UE-lectin 
(Figure 4C). The number of Flk-1+/Sca-1+ cells 
or acLDL+/UE-lectin+ cells was greater in 
the bone marrow from CAP-exposed mice 
than in those from mice exposed to filtered 
Figure 4. CAP exposure enhances the outgrowth of BMDCs isolated from mice exposed to air or CAP for 9 days. Phase contrast images (A) and quantification (B) 
of counted CFUs (fold change) after 2, 4, and 7 days of culture of BMDCs. (C) Fluorescence images of BMDCs labeled with FITC-Sca-1/APC-Flk-1 or DiI-acLDL/
FITC-UE-lectin and DAPI after 7 days of culture. (D) Group data of the number of Flk-1+/Sca-1+ and DiI-acLDL+/UE-lectin+ BMDCs. Data for B and D are presented 
as fold change of air control (mean ± SE; n = 4). 
*p < 0.05. 
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air (Figure 4D). These data confirmed flow 
cytometry results (Figure 3D), showing that 
CAP exposure increases EPC levels in the bone 
marrow. Thus, suppression of circulating EPCs 
in CAP-exposed mice does not appear to be 
a consequence of EPC depletion in the bone 
marrow but perhaps is due to a defect in the 
release of EPCs from the bone marrow.
CAP exposure suppresses VEGF signaling. 
The release of progenitor cells from a stem 
cell niche is a complex multi  step process 
(Heissig et al. 2002; Rafii and Lyden 2003). 
EPCs are maintained in a quiescent state by 
contact with the stromal cells of the bone 
marrow and are mobilized after tissue injury 
in response to VEGF or stromal-derived 
factor-1α (SDF-1α). In the bone marrow, 
VEGF stimulates Akt, and this increases NO 
production by phosphorylating eNOS (Urbich 
and Dimmeler 2004). We found that CAP 
exposure for 9 days did not affect a) plasma 
levels of VEGF or SDF-1α [see Supplemental 
Material, Table 4 (http://dx.doi.org/10.1289/
ehp.1104206)]; b) acetylcholine-induced 
relaxation of the aorta isolated from these 
mice (see Supplemental Material, Table 5); or 
c) levels of VEGFR2 in the aorta (Figure 5A). 
VEGF (20 ng/mL for 15 min) stimulated 
significant increases in both Akt and eNOS 
phosphorylation in aortas isolated from mice 
breathing filtered air; however, these responses 
were abolished in VEGF-stimulated aortas of 
CAP-exposed mice (Figure 5B,C). From these 
data, we conclude that CAP exposure impairs 
vascular VEGF signaling.
We examined whether VEGF-induced 
mobilization of EPCs in mice was also affected 
by 9 days of CAP exposure. On days 6–9 of 
CAP exposure, mice received daily injections 
of VEGF; on day 9, 1 hr before euthanasia, 
mice received a single injection of AMD3100. 
Treatment with VEGF and AMD3100 
(VEGF/AMD3100) led to a 2-fold increase in 
EPC levels in the blood of saline-injected mice 
exposed to filtered air; however, no signifi-
cant increase in circulating levels of EPCs was 
observed in CAP-exposed mice (Figure 6A,B). 
Treatment with VEGF/AMD3100 did not 
affect circulating Sca-1+ cells or the CAP-
induced retention of EPCs in the bone mar-
row [see Supplemental Material, Figure 2A,B 
(http://dx.doi.org/10.1289/ehp.1104206)]. 
These results indicate that CAP exposure pre-
vents VEGF-induced EPC mobilization from 
bone marrow to peripheral blood.
Stimulation of VEGFR2 in bone marrow 
results in MMP-9 activation, which in turn 
cleaves membrane-bound KitL to generate the 
soluble KitL (SCF or steel factor) (Heissig et al. 
2002). The binding of SCF to c-kit [chemokine 
receptor on stem cells (CD117)] on stem cells 
stimulates their mobilization (Thum et al. 
2006). We reasoned that if VEGF-induced 
release of membrane-bound SCF is inhibited 
but the events downstream of c-kit activation 
are not affected, then treatment with SCF 
should rescue CAP-induced EPC suppression. 
To test this hypothesis, we exposed mice to 
CAP for 9 days and then treated them with 
SCF and AMD3100 on the last day of expo-
sure. Flow cytometry revealed that injection of 
SCF and AMD3100 led to a significant increase 
in the circulating level of Flk-1+/Sca-1+ cells 
(Figure 6C,D) in mice breathing filtered air, 
and moreover, SCF/AMD3100 treatment led to 
a significantly greater increase in the number of 
Flk-1+/Sca-1+ cells in the blood of CAP-exposed 
mice. We observed no changes in the circulat-
ing levels of Sca-1+ cells (Figure 6D) or other 
blood cells [see Supplemental Material, Table 6 
(http://dx.doi.org/10.1289/ehp.1104206)]; 
however, SCF/AMD3100 treatment also 
reversed the CAP-induced retention of EPCs in 
the bone marrow (see Supplemental Material, 
Figure 2C,D). From these data we conclude 
that CAP exposure does not affect c-kit sig-
naling and that the CAP-induced decrease in 
circulating EPC levels could be attributed, in 
part, to the inhibition of signaling events that 
are triggered by VEGF/VEGFR2 upstream of 
c-kit activation.
Discussion
Although extensive data indicate that PM 
exposure increases CVD risk, the mecha  nisms 
under  lying the cardio  vascular effects of PM 
remain obscure (Bhatnagar 2006; Brook et al. 
2010). Because PM exposure simultaneously 
affects multiple aspects of CVD, it is plausible 
that exposure affects a common determinant 
of CVD, such as the endothelium. The 
endothelium is a sensitive target of PM, and 
animals and humans exposed to PM show 
endothelial dysfunction (Brook et al. 2011) 
and EPC depletion (O’Toole et al. 2010), 
indicating that PM exposure potentially affects 
the endothelium by acutely causing direct loss 
of flow-mediated dilation and, in the long 
term, attenuating EPC-mediated endothelial 
repair and regeneration. Changes in EPC levels 
may be particularly informative of the chronic 
effects of PM and of the mechanisms by which 
PM exposure increases CVD disease risk.
Current belief is that the levels of circulat-
ing EPCs reflect cardio  vascular health and that 
a reduction in EPC levels promotes CVD. 
Low EPC levels are associated with several 
CVD risk factors and are predictive of future 
cardio  vascular events (Hill et al. 2003; Vasa 
et al. 2001). Although the specific role of 
EPCs in maintaining endothelial function is 
unclear, it has been suggested that a reduction 
in EPC levels decreases normal turnover of 
Figure 5. CAP exposure impairs aortic VEGF-signaling. Representative Western blots and densitometric analysis of VEGFR-2 expression (A) and VEGF-induced 
phosphorylation of Akt (B) and eNOS (C). Western blots were developed from lysates of aortas from mice exposed for 9 days to air or CAP (A) and treated with 
saline or VEGF ex vivo (20 ng/mL for 15 min in autologous plasma). Data presented are mean ± SE (n = 4–8). 
*p < 0.05 compared with the air-exposed saline control. **p < 0.05 compared with air + VEGF. 
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endothelial cells thereby preventing endothe-
lial repair and regeneration (Steinmetz et al. 
2010). Moreover, EPCs promote reendothe-
lialization of arterial lesions, and they suppress 
smooth muscle cell growth (Friedrich et al. 
2006); thus, changes in EPCs could promote 
hypertension and the develop  ment of athero-
sclerotic plaques. Therefore, EPC depletion 
may be one mechanism by which PM expo-
sure increases CVD risk.
In agreement with our previous study 
(O’Toole et al. 2010), we found that CAP 
exposure decreased EPC levels. In addition, the 
present data show that CAP exposure leads to 
an early decrease in circulating levels of EPCs 
at low levels of PM2.5 and that this decrease 
is reversed when the exposure is withdrawn, 
suggesting that at least part of the CVD risk 
imposed by PM exposure may be reversible. 
This is consistent with epidemiological evidence 
showing that, in several U.S. cities, a reduction 
in PM2.5 levels increased life expectancy (Pope 
et al. 2009). A similar reversal of CVD risk 
has also been reported for smoking cessation 
(Chelland Campbell et al. 2008). Exposure to 
tobacco smoke is also associated with changes 
in EPCs; Heiss et al. (2008) reported that 
even a brief 30-min exposure to second  hand 
tobacco smoke impaired VEGF-induced EPC 
mobilization, although in that case exposure 
was associated with an increase rather than a 
decrease in blood EPC levels. Because environ-
mental tobacco smoke is a complex mixture, it 
is difficult to compare the effects of second  hand 
smoke to ambient PM; however, our previ-
ous studies show that short-term (4-day) expo-
sure to acrolein suppressed EPC levels in mice 
(Wheat et al. 2011). Similarly, chronic smoking 
is associated with a profound reduction in circu-
lating EPC levels (Yue et al. 2010) that rebound 
upon cessation (Kondo et al. 2004), suggesting 
that a reversible loss of circulating EPCs may be 
a common response to inhaled pollutants.
Our results indicate that EPC depletion 
in CAP-exposed mice could not be attributed 
to an increase in EPC death or excessive tissue   
recruitment. Instead we found that EPC deple-
tion was associated with VEGF resistance in the 
aorta and in the bone marrow. These observa-
tions suggest that CAP exposure inhibits signal-
ing mechanisms that recruit EPCs from the 
bone marrow to sites of injury. However, this 
defect does not appear to be due to a general 
non  specific suppressive effect of CAP but a 
selective inhibition of VEGF-signaling. This 
notion is supported by the observation that 
CAP exposure did not affect the mobilization 
Figure 6. CAP exposure impairs VEGF-induced but not SCF-mediated mobilization of bone marrow Flk-1+/Sca-1+ cells. (A) Representative flow cytometry plots of 
PE-Sca-1/APC-Flk-1 immuno  labeling of mononuclear blood cells from mice exposed for 9 days to air or CAP and injected with saline or either VEGF/AMD3100 (A) 
or SCF/AMD3100 (B). Changes in levels of Flk-1+/Sca-1+ cells or Sca-1+ cells in mice treated with VEGF/AMD3100 (C) or SCF/AMD3100 (D). Data are presented as 
a percentage of the saline control (mean ± SE; n = 4–9). 
*p < 0.05 compared with air exposure. #p < 0.05 compared with corresponding saline control. 
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or the circulating levels of stem (Sca-1+) cells 
that do not express VEGF-receptor (Flk-1). 
Moreover, even though the Sca-1+ cells were 
mobilized from the bone marrow upon CXCR4 
stimulation (Figure 2C), their mobilization was 
unaffected by CAP exposure, indicating that 
CAP selectively suppress VEGF-sensitive cells. 
A VEGF-selective effect of CAP exposure is also 
consistent with our observation that SCF treat-
ment rescued EPC mobilization and reversed 
bone marrow retention of EPCs.
During EPC mobilization, SCF activation 
is downstream of VEGF signaling. Thus, our 
data suggest that CAP exposure inhibits sig-
naling events downstream of VEGF receptor 
stimulation but upstream of c-kit activation. 
Interestingly, constituents of tobacco smoke 
have also been shown to prevent VEGF sig-
naling in endothelial cells (Edirisinghe et al. 
2010), and exposure to secondhand smoke 
prevents VEGF-induced migration of EPCs 
ex vivo (Heiss et al. 2008). Although molecu-
lar pathways that mediate pollutant-induced 
VEGF resistance have not been identified, 
inhibition of VEGF-signaling by tobacco 
smoke could be prevented by treatment with 
anti  oxidants (Edirisinghe et al. 2010). Hence, 
it is likely that oxidative stress induced by 
PM2.5 components could be one mechanism 
under  lying this defect. Our chemical analyses 
have indicated that the elemental composition 
of Louisville PM2.5 is similar to coal fly ash 
(Smith et al. 2006). It contains high levels of 
organic carbon, metals, and sulfate, each of 
which could potentially induce oxidative stress 
and thereby inhibit VEGF-signaling.
In addition to inhaled pollutants, dia-
betes also suppresses EPC levels (Fadini and 
Avogaro 2010); however, the effects of diabe-
tes appear to be different from those of PM2.5. 
In diabetics, circulating levels of CD34+ cells 
are negatively correlated with the percentage 
of apoptotic CD34+ cells, and thus EPC levels 
are decreased in the peripheral blood due to 
EPC apoptosis and/or bone marrow retention 
(Fadini et al. 2010). In contrast, we found 
that CAP exposure did not trigger EPC apop-
tosis and that it increased EPC number in the 
bone marrow. Thus, the mechanism by which 
PM2.5 suppresses circulating EPC levels may 
be different from that by which diabetes affects 
EPCs. Further identification of the potentially 
unique loci of CAP-induced injury will help 
in distinguishing the effects of PM2.5 from the 
EPC suppressive effects of other insults.
Conclusion
The present study shows that exposure to ambi-
ent PM2.5 suppresses EPC levels by preventing 
their mobilization from the bone marrow due 
to selective impairment of VEGF-signaling. 
Based on these data we suggest that suppres-
sion of EPC levels may significantly contribute 
to endothelial dysfunction and excessive CVD 
risk imposed by long-term PM2.5 exposure. 
Additional studies are required to elucidate the 
molecular mechanism of this phenomenon, 
to identify the specific PM2.5 component(s) 
that affect EPC levels, and to assess long-term 
cardio  vascular consequences of air pollution-
  induced changes in EPC mobilization.
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